Nutra Pharma Corporation

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain.

Recent News

  • Nutra Pharma Provides Updates on Marketing and Distribution

    Coral Springs, Florida--(Newsfile Corp. - March 3, 2020) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodefic

    2020-03-03 9:30 AM ET